129 related articles for article (PubMed ID: 15932639)
1. A systematic review of intravenous gamma globulin for therapy of acute myocarditis.
Robinson JL; Hartling L; Crumley E; Vandermeer B; Klassen TP
BMC Cardiovasc Disord; 2005 Jun; 5(1):12. PubMed ID: 15932639
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
Robinson J; Hartling L; Vandermeer B; Crumley E; Klassen TP
Cochrane Database Syst Rev; 2005 Jan; (1):CD004370. PubMed ID: 15674945
[TBL] [Abstract][Full Text] [Related]
3. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood.
Hollenberg JP; Subak LL; Ferry JJ; Bussel JB
J Pediatr; 1988 Apr; 112(4):530-9. PubMed ID: 2450983
[TBL] [Abstract][Full Text] [Related]
5. Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura.
Bussel J; Pahwa S; Porges A; Cunningham-Rundles S; Koziner B; Morell A; Barandun S
J Clin Immunol; 1986 Jan; 6(1):50-6. PubMed ID: 2420817
[TBL] [Abstract][Full Text] [Related]
6. Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae.
Yanagawa H; Nakamura Y; Sakata K; Yashiro M
Pediatr Cardiol; 1997; 18(1):19-23. PubMed ID: 8960487
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.
Muta H; Ishii M; Furui J; Nakamura Y; Matsuishi T
Acta Paediatr; 2006 Feb; 95(2):189-93. PubMed ID: 16449025
[TBL] [Abstract][Full Text] [Related]
8. Overview of pharmacological treatment of Kawasaki disease.
Onouchi Z; Kawasaki T
Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
[TBL] [Abstract][Full Text] [Related]
9. Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome.
Lekova ES; Joffe L; Glode MP
Pediatr Infect Dis J; 1990 Sep; 9(9):620-3. PubMed ID: 1700361
[TBL] [Abstract][Full Text] [Related]
10. Treatment of dermatomyositis with intravenous gammaglobulin.
Lang BA; Laxer RM; Murphy G; Silverman ED; Roifman CM
Am J Med; 1991 Aug; 91(2):169-72. PubMed ID: 1714236
[TBL] [Abstract][Full Text] [Related]
11. [Dramatic effects of high-dose intravenous gammaglobulin in each patient with intractable dermatomyositis and polymyositis].
Morita R; Nakano K; Hirano Y; Izumi T; Hirayama Y; Suzuki H; Shishikura K; Okada N; Osawa M; Fukuyama Y
No To Hattatsu; 1989 Nov; 21(6):523-8. PubMed ID: 2478176
[TBL] [Abstract][Full Text] [Related]
12. [Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions].
Nürnberger W; Willers R; Körholz D; Göbel U; Wahn V
Monatsschr Kinderheilkd; 1988 Mar; 136(3):116-20. PubMed ID: 3287144
[TBL] [Abstract][Full Text] [Related]
13. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
14. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review.
Hia CP; Yip WC; Tai BC; Quek SC
Arch Dis Child; 2004 Jun; 89(6):580-4. PubMed ID: 15155409
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.
Kleyweg RP; van der Meché FG; Meulstee J
Neurology; 1988 Oct; 38(10):1639-41. PubMed ID: 2458549
[TBL] [Abstract][Full Text] [Related]
18. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin.
Bussel JB; Cunningham-Rundles C; Abraham C
Vox Sang; 1986; 51(4):264-9. PubMed ID: 2432727
[TBL] [Abstract][Full Text] [Related]
19. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
[TBL] [Abstract][Full Text] [Related]
20. Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease.
Jordan SC
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S164-9. PubMed ID: 2477186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
